期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血清CA153、CA125及CA19-9检测对乳腺癌的诊断价值 被引量：9

原文传递
导出
摘要 目的探讨血清CA153、CA125和CA19-9检测对乳腺癌早期诊断的价值。方法采用化学发光免疫法分别检测乳腺癌、乳腺良性疾病患者及正常健康体检者血清CA153、CA125和CA19-9的水平。结果乳腺癌患者血清的CA153、CA125和CA19-9的表达水平及表达阳性率均明显高于正常对照者和乳腺良性疾病患者(P<0.01);乳腺癌患者术后CA153、CA125及CA19-9表达水平较术前明显下降(P<0.01),与正常对照者比较差异无统计学意义(P>0.05)。结论肿瘤标志物CA153、CA125及CA19-9对乳腺癌有一定的诊断价值,且可作为监测乳腺癌病情进展、评估治疗疗效及预后的指标。
作者 刘斌 孙国荣 王从俊 张辉 赵中辛
机构地区 同济大学附属东方医院普外科
出处 《中国普外基础与临床杂志》 CAS 2011年第9期991-992,共2页 Chinese Journal of Bases and Clinics In General Surgery
关键词 CA153 CA125 CA19-9 乳腺癌
分类号 R655.8 [医药卫生—外科学] R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献19

  • 1张嘉庆,王殊,乔新民.乳腺癌的现状和远景[J].中华外科杂志,2002,40(3):161-163. 被引量：76
  • 2Haglund C, Lundin J, Kuusela P, et al. CA242, a new tumour marker for pancreatic cancer., a comparison with CA19-9, CA50 and CEA [J]. Br J Cancer, 1994, 70(3): 487-492.
  • 3Duffy MJ, Shering S, Sherry F, et al. CA15-3: a prognostic marker in breast cancer [J]. Int J Biol Markers, 2000, 15 (4) :330-333.
  • 4Jfinicke F, Prechtl A, Thomssen C, et al; German NO Study Group. Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 [J]. J Natl Cancer Inst, 2001, 93(12) : 913- 920.
  • 5李亚芬.乳腺癌肿瘤标志物的研究和临床应用进展[J].中国普外基础与临床杂志,2002,9(5):298-299. 被引量：11
  • 6Xu Y, Kimura N, Yoshida R, et al. Immunohistochemical study of Muel, Mue2 and human gastrie muein in breast carcinoma: relationship with prognostic faetors [J]. Oncol Rep, 2001, 8(5): 1177-1182.
  • 7Dupont WD, Parl FF, Hartmann WH, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia [J]. Cancer, 1993, 71(4) : 1258-1265.
  • 8Ford HL, Kabingu EN, Bump EA, et al. Abrogation of the G2 cell cycle checkpoint associated with overexpression of HSIX1: A possible mechanism of breast carcinogenesis [J]. Proc Natl Acad Sci U S A, 2004, 95(21): 12608-12613.
  • 9Wang L, Shao ZM. Cyclin E expression and prognosis in breast cancer patients: a rneta-analysis of published studies [J].CaneerInvest, 2006, 24(6): 581-587.
  • 10刘扬清,郑云会.血清CA153检测对复发性乳腺癌的临床价值[J].中国肿瘤临床与康复,2003,10(6):492-494. 被引量：14

二级参考文献37

共引文献198

同被引文献118

  • 1欧阳强.卵巢癌患者治疗前后血清CA125、TGFα和TNFα联检的临床意义[J].医学临床研究,2006,23(4):523-525. 被引量：3
  • 2洪锡田,张瑞丽,白献红.糖类抗原CA125检测在卵巢肿瘤诊断中的应用[J].中国厂矿医学,2007,20(1):23-24. 被引量：6
  • 3Simpson RJ,Bernhard OK,Greening DW,et al. Proteomicsdriven cancer biomarker discovery:looking to the future[J].Curr Opin Chem Biol,2008,12(1):72-77.
  • 4Traub F,Feist H,Kreipe HH,et al. SELDI-MS-based expression profiling of ductal invasive and lobular invasive human breast carcinomas[J]. Pathol Res Pract,2005,201(12):763-770.
  • 5Nakagawa T,Huang SK,Martinez SR,et al. Proteomic profiling of primary breast cancer predicts axillary lymph node metastasis[J]. Cancer Res,2006,66(24):11825-11830.
  • 6Cowherd SM,Espina VA,Petricoin EF 3rd,et al. Proteomic analysis of human breast cancer tissue with laser-capture microdissection and reverse-phase protein microarrays[J]. Clin Breast Cancer,2004,5(5):385-392.
  • 7Sanders ME,Dias EC,Xu BJ,et al. Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS[J]. J Proteome Res,2008,7(4):1500-1507.
  • 8Umar A,Dalebout JC,Timmermans AM,et al. Method optimisation for peptide profiling of microdissected breast carcinoma tissue by matrix-assisted laser desorption/ionisation-time of flight and matrix-assisted laser desorption/ionisation-time of flight/time of flight-mass spectrometry[J]. Proteomics,2005,5(10):2680-2688.
  • 9Leong S,Christopherson RI,Baxter RC. Profiling of apoptotic changes in human breast cancer cells using SELDI-TOF mass spectrometry[J]. Cell Physiol Biochem,2007,20(5):579-590.
  • 10Engwegen JY,Gast MC,Schellens JH,et al. Clinical proteomics:searching for better tumour markers with SELDI-TOF mass spectrometry[J]. Trends Pharmacol Sci,2006,27(5):251-259.

引证文献9

二级引证文献80

中国普外基础与临床杂志
2011年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部